CYTK Market Cap & Key Metrics
Cytokinetics, Incorporated
$65.03
+$1.60(+2.52%)
33
Overall
40
Value
18
Tech
42
Quality
Market Cap
$8.82B
Volume
162.88K
52W Range
$54.30 - $88.31
Target Price
$108.38
CYTK market cap is $8.82B. This page lists Cytokinetics, Incorporated's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
CYTK Key Metrics
- Market cap
- $8.82B
- EPS estimate, current year
- $-5.98
- EPS growth, 3-year
- -14.74%
- Value score
- 40
- Quality score
- 42
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $88.04M | $18.47M | $7.53M | $94.59M | $70.43M |
| EBITDA | -$729.25M | -$542.29M | -$486.05M | -$336.69M | -$183.71M |
| EPS | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CYTK | $65.03 | +2.5% | 162.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cytokinetics, Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW